4//SEC Filing
Glover Nicholas 4
Accession 0001209191-19-016737
CIK 0001290149other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:26 PM ET
Size
5.7 KB
Accession
0001209191-19-016737
Insider Transaction Report
Form 4
Glover Nicholas
DirectorCEO and President
Transactions
- Award
Stock Option (right to buy)
2019-03-04+607,500→ 607,500 totalExercise: $1.96Exp: 2029-03-04→ Common Stock (607,500 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on January 1, 2020, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on January 1, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Sierra Oncology, Inc.
CIK 0001290149
Entity typeother
Related Parties
1- filerCIK 0001578888
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:26 PM ET
- Size
- 5.7 KB